Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-08 17:57 Tx date 2024-09-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-60,671 vol |
0 | |
Filed 2024-09-08 17:57 Tx date 2024-08-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,950
+3,000 vol $0.65 each |
60,671 | |
Filed 2024-09-08 17:56 Tx date 2024-08-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,452
+3,661 vol $0.67 each |
54,010 | |
Filed 2024-09-08 17:55 Tx date 2024-08-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,452
+3,661 vol $0.67 each |
57,671 | |
Filed 2024-09-08 17:54 Tx date 2024-08-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
50,349 | |
Filed 2024-09-08 17:53 Tx date 2024-08-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,306
+3,661 vol $0.63 each |
46,688 | |
Filed 2024-09-08 17:53 Tx date 2024-08-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,306
+3,661 vol $0.63 each |
43,027 | |
Filed 2024-09-08 17:52 Tx date 2024-08-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,306
+3,661 vol $0.63 each |
39,366 | |
Filed 2024-09-08 17:51 Tx date 2024-08-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
35,705 | |
Filed 2024-09-08 17:50 Tx date 2024-08-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
32,044 | |
Filed 2024-09-08 17:50 Tx date 2024-08-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
28,383 | |
Filed 2024-09-08 17:49 Tx date 2024-08-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
24,722 | |
Filed 2024-09-08 17:48 Tx date 2024-08-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,240
+3,500 vol $0.64 each |
21,061 | |
Filed 2024-09-08 17:48 Tx date 2024-08-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,240
+3,500 vol $0.64 each |
17,561 | |
Filed 2024-09-08 17:47 Tx date 2024-08-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,240
+3,500 vol $0.64 each |
14,061 | |
Filed 2024-09-08 17:46 Tx date 2024-08-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,240
+3,500 vol $0.64 each |
10,561 | |
Filed 2024-09-08 17:45 Tx date 2024-08-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,350
+3,561 vol $0.66 each |
142,010 | |
Filed 2024-09-08 17:42 Tx date 2024-08-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,310
+3,500 vol $0.66 each |
138,449 | |
Filed 2024-09-08 17:39 Tx date 2024-08-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-134,949 vol |
7,061 | |
Filed 2024-09-08 17:38 Tx date 2024-07-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,220
+2,000 vol $0.61 each |
134,949 | |
Filed 2024-09-08 17:37 Tx date 2024-07-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,269
+3,661 vol $0.62 each |
132,949 | |
Filed 2024-09-08 17:36 Tx date 2024-07-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,269
+3,661 vol $0.62 each |
129,288 | |
Filed 2024-09-08 17:35 Tx date 2024-07-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,306
+3,661 vol $0.63 each |
125,627 | |
Filed 2024-09-08 17:34 Tx date 2024-07-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
121,966 | |
Filed 2024-09-08 17:34 Tx date 2024-07-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,489
+3,661 vol $0.68 each |
118,305 | |
Filed 2024-09-08 17:32 Tx date 2024-07-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,500
+90,000 vol $0.55 each |
114,644 | |
Filed 2024-09-08 17:30 Tx date 2024-07-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,812
+3,661 vol $0.495 each |
24,644 | |
Filed 2024-09-08 17:29 Tx date 2024-07-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,812
+3,661 vol $0.495 each |
20,983 | |
Filed 2024-09-08 17:28 Tx date 2024-07-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,715
+3,500 vol $0.49 each |
17,322 | |
Filed 2024-09-08 17:27 Tx date 2024-07-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,750
+3,500 vol $0.50 each |
13,822 | |
Filed 2024-09-08 17:25 Tx date 2024-07-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,530
+3,000 vol $0.51 each |
10,322 | |
Filed 2024-09-08 17:24 Tx date 2024-07-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,830
+3,661 vol $0.50 each |
7,322 | |
Filed 2024-09-08 17:23 Tx date 2024-07-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,903
+3,661 vol $0.52 each |
28,127 | |
Filed 2024-09-08 17:19 Tx date 2024-07-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-24,466 vol |
3,661 | |
Filed 2024-09-08 17:18 Tx date 2024-06-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
24,466 | |
Filed 2024-09-08 17:17 Tx date 2024-06-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,522
+3,500 vol $0.435 each |
20,805 | |
Filed 2024-09-08 17:16 Tx date 2024-06-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,537
+3,661 vol $0.42 each |
17,305 | |
Filed 2024-09-08 17:16 Tx date 2024-06-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,574
+3,661 vol $0.43 each |
13,644 | |
Filed 2024-09-08 17:15 Tx date 2024-06-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,574
+3,661 vol $0.43 each |
9,983 | |
Filed 2024-09-08 17:14 Tx date 2024-06-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,144
+2,661 vol $0.43 each |
6,322 | |
Filed 2024-09-08 17:13 Tx date 2024-06-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,555
+3,661 vol $0.425 each |
38,610 | |
Filed 2024-06-06 12:43 Tx date 2024-06-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-34,949 vol |
0 | |
Filed 2024-06-06 12:42 Tx date 2024-05-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,574
+3,661 vol $0.43 each |
34,949 | |
Filed 2024-06-06 12:41 Tx date 2024-05-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,720
+3,661 vol $0.47 each |
31,288 | |
Filed 2024-06-06 12:34 Tx date 2024-05-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,720
+3,661 vol $0.47 each |
27,627 | |
Filed 2024-06-06 12:29 Tx date 2024-05-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,720
+3,661 vol $0.47 each |
23,966 | |
Filed 2024-06-06 12:28 Tx date 2024-05-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,720
+3,661 vol $0.47 each |
20,305 | |
Filed 2024-06-06 12:27 Tx date 2024-05-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,505
+3,500 vol $0.43 each |
16,644 | |
Filed 2024-06-06 12:26 Tx date 2024-05-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,574
+3,661 vol $0.43 each |
13,144 | |
Filed 2024-06-06 12:25 Tx date 2024-05-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,592
+3,661 vol $0.435 each |
9,483 | |
Filed 2024-06-06 12:23 Tx date 2024-05-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,592
+3,661 vol $0.435 each |
5,822 | |
Filed 2024-06-06 12:09 Tx date 2024-05-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$940.03
+2,161 vol $0.435 each |
2,161 | |
Filed 2024-06-06 11:57 Tx date 2024-05-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-39,949 vol |
0 | |
Filed 2024-06-06 11:56 Tx date 2024-04-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,610
+3,661 vol $0.44 each |
39,949 | |
Filed 2024-06-06 11:55 Tx date 2024-04-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,610
+3,661 vol $0.44 each |
36,288 | |
Filed 2024-06-06 11:55 Tx date 2024-04-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,595
+3,661 vol $0.4359 each |
32,627 | |
Filed 2024-06-06 11:54 Tx date 2024-04-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,592
+3,661 vol $0.435 each |
28,966 | |
Filed 2024-06-06 11:53 Tx date 2024-04-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,592
+3,661 vol $0.435 each |
25,305 | |
Filed 2024-06-06 11:52 Tx date 2024-04-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,592
+3,661 vol $0.435 each |
21,644 | |
Filed 2024-06-06 11:51 Tx date 2024-04-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
17,983 | |
Filed 2024-06-06 11:50 Tx date 2024-04-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,540
+3,500 vol $0.44 each |
14,322 | |
Filed 2024-06-06 11:49 Tx date 2024-04-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,540
+3,500 vol $0.44 each |
10,822 | |
Filed 2024-06-06 11:49 Tx date 2024-04-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
7,322 | |
Filed 2024-06-06 11:48 Tx date 2024-04-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
63,932 | |
Filed 2024-04-21 20:52 Tx date 2024-04-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-60,271 vol |
0 | |
Filed 2024-04-21 20:51 Tx date 2024-03-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
60,271 | |
Filed 2024-04-21 20:50 Tx date 2024-03-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
56,610 | |
Filed 2024-04-21 20:49 Tx date 2024-03-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,575
+3,500 vol $0.45 each |
52,949 | |
Filed 2024-04-21 20:48 Tx date 2024-03-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,757
+3,661 vol $0.48 each |
49,449 | |
Filed 2024-04-21 20:47 Tx date 2024-03-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
45,788 | |
Filed 2024-04-21 20:46 Tx date 2024-03-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
42,127 | |
Filed 2024-04-21 20:45 Tx date 2024-03-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,427
+3,661 vol $0.39 each |
38,466 | |
Filed 2024-04-21 20:44 Tx date 2024-03-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
34,805 | |
Filed 2024-04-21 20:43 Tx date 2024-03-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,427
+3,661 vol $0.39 each |
31,144 | |
Filed 2024-04-21 20:41 Tx date 2024-03-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,354
+3,661 vol $0.37 each |
27,483 | |
Filed 2024-04-21 20:35 Tx date 2024-03-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,330
+3,500 vol $0.38 each |
23,822 | |
Filed 2024-04-21 20:34 Tx date 2024-03-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,347
+3,500 vol $0.385 each |
20,322 | |
Filed 2024-04-21 20:33 Tx date 2024-03-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$975.00
+2,500 vol $0.39 each |
16,822 | |
Filed 2024-04-21 20:32 Tx date 2024-03-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
14,322 | |
Filed 2024-04-21 20:31 Tx date 2024-03-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
10,661 | |
Filed 2024-04-21 20:30 Tx date 2024-03-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,400
+3,500 vol $0.40 each |
7,000 | |
Filed 2024-04-21 20:28 Tx date 2024-03-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,400
+3,500 vol $0.40 each |
3,500 | |
Filed 2024-04-21 19:41 Tx date 2024-03-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-44,949 vol |
0 | |
Filed 2024-04-21 19:38 Tx date 2024-02-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,537
+3,661 vol $0.42 each |
44,949 | |
Filed 2024-04-21 19:38 Tx date 2024-02-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,470
+3,500 vol $0.42 each |
41,288 | |
Filed 2024-04-21 19:37 Tx date 2024-02-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,610
+3,661 vol $0.44 each |
37,788 | |
Filed 2024-04-21 19:35 Tx date 2024-02-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
34,127 | |
Filed 2024-04-21 19:34 Tx date 2024-02-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,684
+3,661 vol $0.46 each |
30,466 | |
Filed 2024-04-21 19:33 Tx date 2024-02-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$960.00
+2,000 vol $0.48 each |
26,805 | |
Filed 2024-04-21 19:32 Tx date 2024-02-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,680
+3,500 vol $0.48 each |
24,805 | |
Filed 2024-04-21 19:22 Tx date 2024-03-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,680
+3,500 vol $0.48 each |
3,500 | |
Filed 2024-04-21 19:22 Tx date 2024-03-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,680
+3,500 vol $0.48 each |
||
Filed 2024-04-21 19:22 Tx date 2024-02-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,757
+3,661 vol $0.48 each |
21,305 | |
Filed 2024-04-21 19:21 Tx date 2024-02-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,517
+3,161 vol $0.48 each |
17,644 | |
Filed 2024-04-21 19:19 Tx date 2024-02-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,757
+3,661 vol $0.48 each |
14,483 | |
Filed 2024-04-21 19:18 Tx date 2024-02-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,757
+3,661 vol $0.48 each |
10,822 | |
Filed 2024-04-21 19:17 Tx date 2024-02-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,830
+3,661 vol $0.50 each |
7,161 | |
Filed 2024-04-21 19:16 Tx date 2024-02-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,750
+3,500 vol $0.50 each |
64,788 | |
Filed 2024-01-21 21:28 Tx date 2024-01-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-307,788 vol |
0 | |
Filed 2024-01-21 21:27 Tx date 2023-12-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,757
+3,661 vol $0.48 each |
307,788 | |
Filed 2024-01-21 21:24 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
304,127 | |
Filed 2024-01-21 21:23 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,574
+3,661 vol $0.43 each |
300,466 | |
Filed 2024-01-21 21:23 Tx date 2023-12-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,647
+3,661 vol $0.45 each |
296,805 | |
Filed 2024-01-21 21:22 Tx date 2023-12-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$400.00
+1,000 vol $0.40 each |
293,144 | |
Filed 2024-01-21 21:21 Tx date 2023-12-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,400
+3,500 vol $0.40 each |
292,144 | |
Filed 2024-01-21 21:20 Tx date 2023-12-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,470
+3,500 vol $0.42 each |
288,644 | |
Filed 2024-01-21 21:18 Tx date 2023-12-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,427
+3,661 vol $0.39 each |
285,144 | |
Filed 2024-01-21 21:17 Tx date 2023-12-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,935
+266,500 vol $0.39 each |
281,483 | |
Filed 2024-01-21 21:16 Tx date 2023-12-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$142,779
+3,661 vol $39.00 each |
14,983 | |
Filed 2024-01-21 21:15 Tx date 2023-12-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,400
+3,500 vol $0.40 each |
11,322 | |
Filed 2024-01-21 21:15 Tx date 2023-12-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
7,822 | |
Filed 2024-01-21 21:11 Tx date 2023-12-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,464
+3,661 vol $0.40 each |
4,161 | |
Filed 2024-01-21 21:11 Tx date 2023-12-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$200.00
+500 vol $0.40 each |
33,983 | |
Filed 2024-01-02 23:09 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$9,200
+20,000 vol $0.46 each |
47,000 | |
Filed 2024-01-02 23:07 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564
+3,400 vol $0.46 each |
59,500 | |
Filed 2024-01-02 23:00 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$6,900
+15,000 vol $0.46 each |
42,000 | |
Filed 2024-01-02 22:55 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564
+3,400 vol $0.46 each |
257,000 | |
Filed 2024-01-02 22:52 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$9,200
+20,000 vol $0.46 each |
54,500 | |
Filed 2024-01-02 22:49 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564
+3,400 vol $0.46 each |
134,500 | |
Filed 2024-01-02 22:43 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$82,800
+180,000 vol $0.46 each |
450,000 | |
Filed 2024-01-02 22:41 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,998
+52,171 vol $0.46 each |
997,771 | |
Filed 2024-01-02 22:38 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$41,400
+90,000 vol $0.46 each |
183,000 | |
Filed 2024-01-02 22:32 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,730
+25,500 vol $0.46 each |
423,000 | |
Filed 2023-12-29 15:56 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,644
+15,100 vol $0.44 each |
49,600 | |
Filed 2023-12-29 15:55 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,870
+34,500 vol $0.46 each |
34,500 | |
Filed 2023-12-29 15:54 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-12-29 15:47 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,030
+21,000 vol $0.43 each |
32,800 | |
Filed 2023-12-29 15:40 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,350
+10,000 vol $0.435 each |
659,351 | |
Filed 2023-12-29 09:15 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,112
+33,443 vol $0.4818 each |
250,001 | |
Filed 2023-12-29 09:07 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,752
+25,500 vol $0.4609 each |
216,558 | |
Filed 2023-12-29 09:06 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,540
+20,000 vol $0.477 each |
191,058 | |
Filed 2023-12-29 09:05 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,100
+30,000 vol $0.47 each |
171,058 | |
Filed 2023-12-27 09:07 Tx date 2023-12-22 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,405
+33,500 vol $0.43 each |
141,058 | |
Filed 2023-12-27 09:05 Tx date 2023-12-20 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+1,000 vol $0.40 each |
107,558 | |
Filed 2023-12-10 22:51 Tx date 2023-12-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-33,483 vol |
0 | |
Filed 2023-12-10 22:50 Tx date 2023-11-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,435
+3,500 vol $0.41 each |
33,483 | |
Filed 2023-12-10 22:50 Tx date 2023-11-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,025
+2,500 vol $0.41 each |
29,983 | |
Filed 2023-12-10 22:49 Tx date 2023-11-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,435
+3,500 vol $0.41 each |
27,483 | |
Filed 2023-12-10 22:48 Tx date 2023-11-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,470
+3,500 vol $0.42 each |
23,983 | |
Filed 2023-12-10 22:47 Tx date 2023-11-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,435
+3,500 vol $0.41 each |
20,483 | |
Filed 2023-12-10 22:45 Tx date 2023-11-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,537
+3,661 vol $0.42 each |
16,983 | |
Filed 2023-12-10 22:41 Tx date 2023-11-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,575
+3,500 vol $0.45 each |
13,322 | |
Filed 2023-12-10 22:38 Tx date 2023-11-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,793
+3,661 vol $0.49 each |
9,822 | |
Filed 2023-12-10 22:38 Tx date 2023-11-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,233
+3,661 vol $0.61 each |
6,161 | |
Filed 2023-12-10 22:37 Tx date 2023-11-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$915.00
+1,500 vol $0.61 each |
2,500 | |
Filed 2023-12-10 22:36 Tx date 2023-11-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$600.00
+1,000 vol $0.60 each |
31,144 | |
Filed 2023-11-12 14:24 Tx date 2023-11-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-30,144 vol |
0 | |
Filed 2023-11-12 14:14 Tx date 2023-10-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,100
+3,500 vol $0.60 each |
30,144 | |
Filed 2023-11-12 14:10 Tx date 2023-10-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
26,644 | |
Filed 2023-11-12 14:10 Tx date 2023-10-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
22,983 | |
Filed 2023-11-12 14:09 Tx date 2023-10-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,343
+3,661 vol $0.64 each |
19,322 | |
Filed 2023-11-12 14:07 Tx date 2023-10-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,269
+3,661 vol $0.62 each |
15,661 | |
Filed 2023-11-12 14:06 Tx date 2023-10-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,170
+3,500 vol $0.62 each |
12,000 | |
Filed 2023-11-12 14:05 Tx date 2023-10-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
$2,205
+3,500 vol $0.63 each |
8,500 | |
Filed 2023-11-12 14:04 Tx date 2023-10-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,205
+3,500 vol $0.63 each |
5,000 | |
Filed 2023-11-12 14:03 Tx date 2023-10-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$945.00
+1,500 vol $0.63 each |
1,500 | |
Filed 2023-10-10 15:45 Tx date 2023-10-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-355,110 vol |
0 | |
Filed 2023-10-10 15:44 Tx date 2023-09-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,005
+1,500 vol $0.67 each |
355,110 | |
Filed 2023-10-10 15:44 Tx date 2023-09-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,452
+3,661 vol $0.67 each |
353,610 | |
Filed 2023-10-10 15:42 Tx date 2023-09-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,526
+3,661 vol $0.69 each |
349,949 | |
Filed 2023-10-10 15:42 Tx date 2023-09-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,526
+3,661 vol $0.69 each |
346,288 | |
Filed 2023-10-10 15:41 Tx date 2023-09-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,526
+3,661 vol $0.69 each |
342,627 | |
Filed 2023-10-10 15:40 Tx date 2023-09-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
338,966 | |
Filed 2023-10-10 15:39 Tx date 2023-09-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
335,466 | |
Filed 2023-10-10 15:38 Tx date 2023-09-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,452
+3,661 vol $0.67 each |
331,966 | |
Filed 2023-10-10 15:37 Tx date 2023-09-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,562
+3,661 vol $0.70 each |
328,305 | |
Filed 2023-10-10 15:37 Tx date 2023-09-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,562
+3,661 vol $0.70 each |
324,644 | |
Filed 2023-10-10 15:36 Tx date 2023-09-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$208,420
+306,500 vol $0.68 each |
320,983 | |
Filed 2023-10-10 15:35 Tx date 2023-09-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,599
+3,661 vol $0.71 each |
14,483 | |
Filed 2023-10-10 15:34 Tx date 2023-09-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,489
+3,661 vol $0.68 each |
10,822 | |
Filed 2023-10-10 15:33 Tx date 2023-09-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,562
+3,661 vol $0.70 each |
7,161 | |
Filed 2023-10-10 15:33 Tx date 2023-09-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,380
+3,500 vol $0.68 each |
3,500 | |
Filed 2023-09-05 13:05 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,178
+3,300 vol $0.66 each |
56,100 | |
Filed 2023-09-05 13:02 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,178
+3,300 vol $0.66 each |
131,100 | |
Filed 2023-09-05 13:00 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,178
+3,300 vol $0.66 each |
253,600 | |
Filed 2023-09-05 12:57 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,147
+13,860 vol $0.66 each |
126,720 | |
Filed 2023-09-05 12:55 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,335
+24,750 vol $0.66 each |
397,500 | |
Filed 2023-09-05 12:52 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,848
+52,800 vol $0.66 each |
945,600 | |
Filed 2023-06-25 23:25 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+18,077 vol $0.65 each |
77,945 | |
Filed 2023-06-25 23:23 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+18,077 vol $0.65 each |
51,710 | |
Filed 2023-06-25 23:21 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+18,077 vol $0.65 each |
51,710 | |
Filed 2023-06-25 23:16 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+18,077 vol $0.65 each |
51,710 | |
Filed 2023-06-25 23:10 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,145
+3,300 vol $0.65 each |
52,800 | |
Filed 2023-06-25 23:08 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,145
+3,300 vol $0.65 each |
127,800 | |
Filed 2023-06-25 23:04 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,145
+3,300 vol $0.65 each |
250,300 | |
Filed 2023-06-25 23:01 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,009
+13,860 vol $0.65 each |
112,860 | |
Filed 2023-06-25 22:59 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,087
+24,750 vol $0.65 each |
372,750 | |
Filed 2023-06-25 22:55 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,320
+52,800 vol $0.65 each |
892,800 | |
Filed 2023-01-22 13:38 Tx date 2022-12-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-32,080 vol |
0 | |
Filed 2023-01-22 13:37 Tx date 2022-12-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
32,080 | |
Filed 2023-01-22 13:37 Tx date 2022-12-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
28,310 | |
Filed 2023-01-22 13:36 Tx date 2022-12-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,380
+3,500 vol $0.68 each |
24,540 | |
Filed 2023-01-22 13:35 Tx date 2022-12-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,384
+3,500 vol $0.68 each |
21,040 | |
Filed 2023-01-22 13:34 Tx date 2022-12-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,950
+3,000 vol $0.65 each |
17,540 | |
Filed 2023-01-22 13:33 Tx date 2022-12-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,240
+3,500 vol $0.64 each |
14,540 | |
Filed 2023-01-22 13:32 Tx date 2022-12-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
11,040 | |
Filed 2023-01-22 13:32 Tx date 2022-12-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,240
+3,500 vol $0.64 each |
42,120 | |
Filed 2023-01-22 13:31 Tx date 2022-12-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,412
+3,770 vol $0.64 each |
38,620 | |
Filed 2022-12-12 08:25 Tx date 2022-12-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-34,850 vol |
0 | |
Filed 2022-12-08 09:36 Tx date 2022-11-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
34,850 | |
Filed 2022-12-08 09:35 Tx date 2022-11-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
31,080 | |
Filed 2022-12-08 09:35 Tx date 2022-11-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,563
+3,770 vol $0.68 each |
27,310 | |
Filed 2022-12-08 09:34 Tx date 2022-11-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
23,540 | |
Filed 2022-12-08 09:32 Tx date 2022-11-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,310
+3,500 vol $0.66 each |
19,770 | |
Filed 2022-12-08 09:30 Tx date 2022-11-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,310
+3,500 vol $0.66 each |
12,770 | |
Filed 2022-12-08 08:40 Tx date 2022-11-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,310
+3,500 vol $0.66 each |
12,770 | |
Filed 2022-12-08 08:38 Tx date 2022-11-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
9,270 | |
Filed 2022-12-08 08:37 Tx date 2022-11-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,360
+2,000 vol $0.68 each |
5,500 | |
Filed 2022-12-08 08:36 Tx date 2022-11-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,205
+3,500 vol $0.63 each |
44,160 | |
Filed 2022-11-10 16:42 Tx date 2022-11-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-40,660 vol |
0 | |
Filed 2022-11-10 16:41 Tx date 2022-10-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
40,660 | |
Filed 2022-11-10 16:41 Tx date 2022-10-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,412
+3,770 vol $0.64 each |
36,890 | |
Filed 2022-11-10 16:40 Tx date 2022-10-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,205
+3,500 vol $0.63 each |
33,120 | |
Filed 2022-11-10 16:39 Tx date 2022-10-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,890
+3,000 vol $0.63 each |
29,620 | |
Filed 2022-11-10 16:38 Tx date 2022-10-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,260
+2,000 vol $0.63 each |
26,620 | |
Filed 2022-11-10 16:38 Tx date 2022-10-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
24,620 | |
Filed 2022-11-10 16:37 Tx date 2022-10-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
20,850 | |
Filed 2022-11-10 16:36 Tx date 2022-10-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
17,080 | |
Filed 2022-11-10 16:35 Tx date 2022-10-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,262
+3,770 vol $0.60 each |
13,310 | |
Filed 2022-11-10 16:35 Tx date 2022-10-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,262
+3,770 vol $0.60 each |
9,540 | |
Filed 2022-11-10 16:34 Tx date 2022-10-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,299
+3,770 vol $0.61 each |
5,770 | |
Filed 2022-11-10 16:33 Tx date 2022-10-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,220
+2,000 vol $0.61 each |
40,350 | |
Filed 2022-10-06 09:17 Tx date 2022-10-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-38,350 vol |
0 | |
Filed 2022-10-06 09:17 Tx date 2022-09-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,299
+3,770 vol $0.61 each |
38,350 | |
Filed 2022-10-06 09:15 Tx date 2022-09-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,135
+3,500 vol $0.61 each |
34,580 | |
Filed 2022-10-06 09:15 Tx date 2022-09-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
31,080 | |
Filed 2022-10-06 09:14 Tx date 2022-09-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
27,310 | |
Filed 2022-10-06 09:12 Tx date 2022-09-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
23,540 | |
Filed 2022-10-06 09:11 Tx date 2022-09-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
20,040 | |
Filed 2022-10-06 09:10 Tx date 2022-09-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
16,540 | |
Filed 2022-10-06 09:09 Tx date 2022-09-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,563
+3,770 vol $0.68 each |
13,040 | |
Filed 2022-10-06 09:08 Tx date 2022-09-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
9,270 | |
Filed 2022-10-06 09:07 Tx date 2022-09-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,340
+2,000 vol $0.67 each |
5,770 | |
Filed 2022-10-06 09:07 Tx date 2022-09-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
204,580 | |
Filed 2022-09-08 16:48 Tx date 2022-09-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-200,810 vol |
0 | |
Filed 2022-09-08 16:47 Tx date 2022-08-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,380
+3,500 vol $0.68 each |
200,810 | |
Filed 2022-09-08 16:46 Tx date 2022-08-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,463
+3,770 vol $0.65 each |
197,310 | |
Filed 2022-09-08 16:44 Tx date 2022-08-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,415
+3,500 vol $0.69 each |
193,540 | |
Filed 2022-09-08 16:43 Tx date 2022-08-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
186,270 | |
Filed 2022-09-08 16:42 Tx date 2022-08-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
190,040 | |
Filed 2022-09-08 16:42 Tx date 2022-08-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,660
+3,500 vol $0.76 each |
182,770 | |
Filed 2022-09-08 16:41 Tx date 2022-08-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$110,250
+175,000 vol $0.63 each |
179,270 | |
Filed 2022-09-08 16:40 Tx date 2022-08-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$945.00
+1,500 vol $0.63 each |
4,270 | |
Filed 2022-09-08 16:37 Tx date 2022-08-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,800
+2,770 vol $0.65 each |
38,390 | |
Filed 2022-08-21 07:39 Tx date 2022-08-16 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,749
+15,638 vol $0.69 each |
100,000 | |
Filed 2022-08-21 07:36 Tx date 2022-08-16 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,992.98
-14,100 vol $0.64 each |
0 | |
Filed 2022-08-21 07:33 Tx date 2022-08-16 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-984.32
-1,538 vol $0.64 each |
0 | |
Filed 2022-08-10 11:04 Tx date 2022-08-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-35,620 vol |
0 | |
Filed 2022-08-10 11:00 Tx date 2022-07-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$325.00
+500 vol $0.65 each |
35,620 | |
Filed 2022-08-10 11:00 Tx date 2022-07-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,220
+2,000 vol $0.61 each |
35,120 | |
Filed 2022-08-10 10:59 Tx date 2022-07-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,281
+3,770 vol $0.61 each |
33,120 | |
Filed 2022-08-10 10:58 Tx date 2022-07-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
29,350 | |
Filed 2022-08-10 10:57 Tx date 2022-07-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
25,580 | |
Filed 2022-08-10 10:56 Tx date 2022-07-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,563
+3,770 vol $0.68 each |
21,810 | |
Filed 2022-08-10 10:56 Tx date 2022-07-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,275
+3,500 vol $0.65 each |
18,040 | |
Filed 2022-08-10 10:55 Tx date 2022-07-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
14,540 | |
Filed 2022-08-10 10:54 Tx date 2022-07-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
10,770 | |
Filed 2022-08-10 10:54 Tx date 2022-07-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,275
+3,500 vol $0.65 each |
54,930 | |
Filed 2022-08-10 10:53 Tx date 2022-07-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,275
+3,500 vol $0.65 each |
51,430 | |
Filed 2022-07-12 12:59 Tx date 2022-07-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-47,930 vol |
0 | |
Filed 2022-07-12 12:54 Tx date 2022-06-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
47,930 | |
Filed 2022-07-12 12:52 Tx date 2022-06-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
44,160 | |
Filed 2022-07-12 12:51 Tx date 2022-06-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,275
+3,500 vol $0.65 each |
40,390 | |
Filed 2022-07-12 12:51 Tx date 2022-06-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
36,890 | |
Filed 2022-07-12 12:49 Tx date 2022-06-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
33,120 | |
Filed 2022-07-12 12:48 Tx date 2022-06-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,345
+3,500 vol $0.67 each |
29,350 | |
Filed 2022-07-12 12:46 Tx date 2022-06-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,563
+3,770 vol $0.68 each |
25,850 | |
Filed 2022-07-12 12:44 Tx date 2022-06-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,415
+3,500 vol $0.69 each |
22,080 | |
Filed 2022-07-12 12:43 Tx date 2022-06-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,415
+3,500 vol $0.69 each |
18,580 | |
Filed 2022-07-12 12:42 Tx date 2022-06-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,563
+3,770 vol $0.68 each |
70,010 | |
Filed 2022-07-12 12:42 Tx date 2022-06-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
66,240 | |
Filed 2022-07-12 12:41 Tx date 2022-06-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
58,700 | |
Filed 2022-07-12 12:41 Tx date 2022-06-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
62,470 | |
Filed 2022-06-15 15:11 Tx date 2022-06-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-54,930 vol |
0 | |
Filed 2022-06-15 15:10 Tx date 2022-05-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
54,930 | |
Filed 2022-06-15 15:10 Tx date 2022-05-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,500 vol $0.70 each |
51,160 | |
Filed 2022-06-15 15:08 Tx date 2022-05-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,500 vol $0.70 each |
47,660 | |
Filed 2022-06-15 15:08 Tx date 2022-05-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
44,160 | |
Filed 2022-06-15 15:07 Tx date 2022-05-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
40,390 | |
Filed 2022-06-15 15:04 Tx date 2022-05-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
36,620 | |
Filed 2022-06-15 15:02 Tx date 2022-05-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
32,850 | |
Filed 2022-06-15 15:00 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,520
+3,500 vol $0.72 each |
29,080 | |
Filed 2022-06-15 15:00 Tx date 2022-05-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
25,580 | |
Filed 2022-06-15 14:59 Tx date 2022-05-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,714
+3,770 vol $0.72 each |
21,810 | |
Filed 2022-06-15 14:58 Tx date 2022-05-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,563
+3,770 vol $0.68 each |
18,040 | |
Filed 2022-06-15 14:58 Tx date 2022-05-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
14,270 | |
Filed 2022-06-15 14:57 Tx date 2022-05-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
7,000 | |
Filed 2022-06-15 14:56 Tx date 2022-05-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
10,500 | |
Filed 2022-06-15 14:56 Tx date 2022-05-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,500 vol $0.70 each |
44,390 | |
Filed 2022-05-17 13:05 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
59,868 | |
Filed 2022-05-17 13:03 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
Filed 2022-05-17 12:57 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
Filed 2022-05-17 12:55 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
Filed 2022-05-17 12:52 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
Filed 2022-05-17 12:47 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
Filed 2022-05-17 12:10 Tx date 2022-05-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-40,890 vol |
0 | |
Filed 2022-05-17 12:10 Tx date 2022-04-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,676
+3,770 vol $0.71 each |
40,890 | |
Filed 2022-05-17 12:09 Tx date 2022-04-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,676
+3,770 vol $0.71 each |
37,120 | |
Filed 2022-05-17 12:08 Tx date 2022-04-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,752
+3,770 vol $0.73 each |
33,350 | |
Filed 2022-05-17 12:07 Tx date 2022-04-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,827
+3,770 vol $0.75 each |
29,580 | |
Filed 2022-05-17 12:07 Tx date 2022-04-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
25,810 | |
Filed 2022-05-17 12:02 Tx date 2022-04-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
22,040 | |
Filed 2022-05-17 12:01 Tx date 2022-04-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
18,540 | |
Filed 2022-05-17 12:00 Tx date 2022-04-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,190
+3,000 vol $0.73 each |
11,540 | |
Filed 2022-05-17 11:59 Tx date 2022-04-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,555
+3,500 vol $0.73 each |
12,040 | |
Filed 2022-05-17 11:58 Tx date 2022-04-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,940
+3,770 vol $0.78 each |
8,540 | |
Filed 2022-05-17 11:54 Tx date 2022-04-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$760.00
+1,000 vol $0.76 each |
4,770 | |
Filed 2022-05-17 11:51 Tx date 2022-04-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,978
+3,770 vol $0.79 each |
62,970 | |
Filed 2022-05-17 11:47 Tx date 2022-04-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-59,200 vol |
3,770 | |
Filed 2022-05-17 11:46 Tx date 2022-03-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,925
+2,500 vol $0.77 each |
59,200 | |
Filed 2022-05-17 11:33 Tx date 2022-03-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,865
+3,770 vol $0.76 each |
56,700 | |
Filed 2022-05-17 11:32 Tx date 2022-03-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,660
+3,500 vol $0.76 each |
52,930 | |
Filed 2022-05-17 11:31 Tx date 2022-03-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,730
+3,500 vol $0.78 each |
49,430 | |
Filed 2022-05-17 11:29 Tx date 2022-03-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,978
+3,770 vol $0.79 each |
45,930 | |
Filed 2022-05-17 11:28 Tx date 2022-03-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,789
+3,770 vol $0.74 each |
42,160 | |
Filed 2022-05-17 11:27 Tx date 2022-03-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$945.00
+1,500 vol $0.63 each |
38,390 | |
Filed 2022-05-17 11:26 Tx date 2022-03-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
36,890 | |
Filed 2022-05-17 11:24 Tx date 2022-03-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,337
+3,770 vol $0.62 each |
33,120 | |
Filed 2022-05-17 11:21 Tx date 2022-03-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,299
+3,770 vol $0.61 each |
29,350 | |
Filed 2022-05-17 11:21 Tx date 2022-03-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,337
+3,770 vol $0.62 each |
25,580 | |
Filed 2022-05-17 11:19 Tx date 2022-03-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,337
+3,770 vol $0.62 each |
21,810 | |
Filed 2022-05-17 11:19 Tx date 2022-03-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,170
+3,500 vol $0.62 each |
18,040 | |
Filed 2022-05-17 10:59 Tx date 2022-03-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
14,540 | |
Filed 2022-05-17 10:57 Tx date 2022-03-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,375
+3,770 vol $0.63 each |
10,770 | |
Filed 2022-05-17 10:54 Tx date 2022-03-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,275
+3,500 vol $0.65 each |
7,000 | |
Filed 2022-05-17 10:53 Tx date 2022-03-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,380
+3,500 vol $0.68 each |
40,350 | |
Filed 2022-04-03 21:21 Tx date 2022-03-29 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-44,368 vol |
117,658 | |
Filed 2022-04-03 21:17 Tx date 2022-03-29 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-44,368 vol |
691,158 | |
Filed 2022-03-08 20:50 Tx date 2022-03-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-36,850 vol |
0 | |
Filed 2022-03-08 20:48 Tx date 2022-02-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,380
+3,500 vol $0.68 each |
36,850 | |
Filed 2022-03-08 20:48 Tx date 2022-02-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$680.00
+1,000 vol $0.68 each |
33,350 | |
Filed 2022-03-08 20:47 Tx date 2022-02-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
32,350 | |
Filed 2022-03-08 20:43 Tx date 2022-02-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,485
+3,500 vol $0.71 each |
28,850 | |
Filed 2022-03-08 20:41 Tx date 2022-02-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
25,350 | |
Filed 2022-03-08 20:40 Tx date 2022-02-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
21,580 | |
Filed 2022-03-08 20:39 Tx date 2022-02-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,500 vol $0.70 each |
17,810 | |
Filed 2022-03-08 20:39 Tx date 2022-02-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$710.00
+1,000 vol $0.71 each |
14,310 | |
Filed 2022-03-08 20:37 Tx date 2022-02-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
13,310 | |
Filed 2022-03-08 20:36 Tx date 2022-02-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
9,540 | |
Filed 2022-03-08 20:35 Tx date 2022-02-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,525
+3,770 vol $0.67 each |
5,770 | |
Filed 2022-03-08 20:34 Tx date 2022-02-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,280
+2,000 vol $0.64 each |
26,350 | |
Filed 2022-02-08 09:10 Tx date 2022-02-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-24,350 vol |
0 | |
Filed 2022-02-08 09:06 Tx date 2022-01-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,275
+3,500 vol $0.65 each |
24,350 | |
Filed 2022-02-08 09:05 Tx date 2022-01-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,601
+3,770 vol $0.69 each |
20,850 | |
Filed 2022-02-08 09:02 Tx date 2022-01-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
17,080 | |
Filed 2022-02-08 09:00 Tx date 2022-01-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,639
+3,770 vol $0.70 each |
13,310 | |
Filed 2022-02-08 08:56 Tx date 2022-01-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,360
+2,000 vol $0.68 each |
9,540 | |
Filed 2022-02-08 08:56 Tx date 2022-01-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,412
+3,770 vol $0.64 each |
7,540 | |
Filed 2022-02-08 08:55 Tx date 2022-01-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,412
+3,770 vol $0.64 each |
20,850 | |
Filed 2022-01-07 13:25 Tx date 2022-01-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-17,080 vol |
0 | |
Filed 2022-01-07 13:24 Tx date 2021-12-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
17,080 | |
Filed 2022-01-07 13:24 Tx date 2021-12-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,320
+2,000 vol $0.66 each |
13,310 | |
Filed 2022-01-07 13:23 Tx date 2021-12-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
11,310 | |
Filed 2022-01-07 13:23 Tx date 2021-12-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,488
+3,770 vol $0.66 each |
7,540 | |
Filed 2022-01-07 13:22 Tx date 2021-12-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,450
+3,770 vol $0.65 each |
3,770 | |
Filed 2022-01-05 12:11 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+12,000 vol |
27,000 | |
Filed 2022-01-05 12:07 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+12,000 vol |
34,500 | |
Filed 2022-01-05 12:03 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+12,000 vol |
27,000 | |
Filed 2022-01-05 11:58 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+24,000 vol |
24,000 | |
Filed 2022-01-05 11:56 Tx date 2021-05-10 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-01-05 11:55 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+48,000 vol |
93,000 | |
Filed 2022-01-05 11:49 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+120,000 vol |
270,000 | |
Filed 2022-01-05 11:44 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
49,500 | |
Filed 2022-01-05 11:33 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
124,500 | |
Filed 2022-01-05 11:27 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
247,000 | |
Filed 2022-01-05 11:23 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,000 vol |
99,000 | |
Filed 2022-01-05 11:18 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
348,000 | |
Filed 2022-01-05 11:13 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,000 vol |
840,000 | |
Filed 2021-12-28 12:01 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+8,697 vol |
43,772 | |
Filed 2021-12-28 12:00 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+35,075 vol |
35,075 | |
Filed 2021-12-28 11:58 Tx date 2021-11-10 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-28 11:53 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
Filed 2021-12-28 11:52 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-28 11:44 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
Filed 2021-12-28 11:43 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-28 11:40 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
Filed 2021-12-28 11:38 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-28 11:34 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
Filed 2021-12-28 11:32 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-28 11:26 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
Filed 2021-12-28 11:22 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-17 17:08 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,170
+3,500 vol $0.62 each |
11,900 | |
Filed 2021-12-17 17:07 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,210
+3,400 vol $0.65 each |
8,400 | |
Filed 2021-12-17 17:07 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,400
+5,000 vol $0.68 each |
5,000 | |
Filed 2021-12-17 17:06 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-17 16:47 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+500 vol $0.62 each |
11,800 | |
Filed 2021-12-17 16:46 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,860
+3,000 vol $0.62 each |
11,300 | |
Filed 2021-12-17 16:45 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+5,000 vol $0.65 each |
8,300 | |
Filed 2021-12-17 16:45 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+2,000 vol $0.65 each |
3,300 | |
Filed 2021-12-17 16:44 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+1,000 vol $0.65 each |
1,300 | |
Filed 2021-12-17 16:42 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$195.00
+300 vol $0.65 each |
300 | |
Filed 2021-12-17 16:42 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-16 21:46 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,170
+3,500 vol $0.62 each |
106,558 | |
Filed 2021-12-16 21:44 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,625
+2,500 vol $0.65 each |
103,058 | |
Filed 2021-12-16 12:44 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,500
+75,000 vol $0.62 each |
75,000 | |
Filed 2021-12-16 12:41 Tx date 2021-05-10 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-16 12:14 Tx date 2021-12-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-37,456 vol |
0 | |
Filed 2021-12-16 12:13 Tx date 2021-11-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,039
+5,152 vol $0.59 each |
37,456 | |
Filed 2021-12-16 12:12 Tx date 2021-11-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,039
+5,152 vol $0.59 each |
32,304 | |
Filed 2021-12-16 12:10 Tx date 2021-11-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,750
+5,000 vol $0.55 each |
27,152 | |
Filed 2021-12-16 12:09 Tx date 2021-11-22 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,091
+5,152 vol $0.60 each |
22,152 | |
Filed 2021-12-16 12:08 Tx date 2021-11-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,050
+5,000 vol $0.61 each |
17,000 | |
Filed 2021-12-16 12:08 Tx date 2021-11-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,925
+4,500 vol $0.65 each |
12,000 | |
Filed 2021-12-16 12:07 Tx date 2021-11-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
7,500 | |
Filed 2021-12-16 12:06 Tx date 2021-11-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$345.00
+500 vol $0.69 each |
2,500 | |
Filed 2021-12-16 12:05 Tx date 2021-11-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,400
+2,000 vol $0.70 each |
27,804 | |
Filed 2021-11-22 12:33 Tx date 2021-11-10 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-11-15 10:06 Tx date 2021-11-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-25,804 vol |
0 | |
Filed 2021-11-15 10:05 Tx date 2021-10-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,554
+5,152 vol $0.69 each |
25,804 | |
Filed 2021-11-15 10:05 Tx date 2021-10-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,800
+4,000 vol $0.70 each |
20,652 | |
Filed 2021-11-15 10:04 Tx date 2021-10-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,449
+5,000 vol $0.69 each |
16,652 | |
Filed 2021-11-15 10:03 Tx date 2021-10-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
$3,606
+5,152 vol $0.70 each |
11,652 | |
Filed 2021-11-15 10:03 Tx date 2021-10-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,400
+2,000 vol $0.70 each |
6,500 | |
Filed 2021-11-15 10:02 Tx date 2021-10-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,380
+2,000 vol $0.69 each |
4,500 | |
Filed 2021-11-15 10:02 Tx date 2021-10-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,724
+2,500 vol $0.69 each |
2,500 | |
Filed 2021-11-15 09:46 Tx date 2021-10-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-15,804 vol |
0 | |
Filed 2021-11-15 09:44 Tx date 2021-09-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,606
+5,152 vol $0.70 each |
15,804 | |
Filed 2021-11-15 09:44 Tx date 2021-09-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$350.00
+500 vol $0.70 each |
10,652 | |
Filed 2021-11-15 09:41 Tx date 2021-09-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,554
+5,152 vol $0.69 each |
10,152 | |
Filed 2021-11-15 09:40 Tx date 2021-08-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,449
+5,000 vol $0.69 each |
26,152 | |
Filed 2021-09-08 16:22 Tx date 2021-09-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-21,152 vol |
0 | |
Filed 2021-09-08 16:21 Tx date 2021-08-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
15,000 | |
Filed 2021-09-08 16:20 Tx date 2021-09-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-11,306.40
-16,152 vol $0.70 each |
||
Filed 2021-09-08 16:06 Tx date 2021-09-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-11,306.40
-16,152 vol $0.70 each |
||
Filed 2021-09-08 16:04 Tx date 2021-08-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,606
+5,152 vol $0.70 each |
21,152 | |
Filed 2021-09-08 16:02 Tx date 2021-08-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$700.00
+1,000 vol $0.70 each |
16,000 | |
Filed 2021-09-08 15:59 Tx date 2021-08-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
10,000 | |
Filed 2021-09-08 15:58 Tx date 2021-08-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
5,000 | |
Filed 2021-08-26 16:33 Tx date 2021-08-16 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-7,418.0568
-6,153 vol $1.21 each |
58,500 | |
Filed 2021-08-26 16:20 Tx date 2021-08-16 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-7,418.0568
-6,153 vol $1.21 each |
58,500 | |
Filed 2021-08-26 15:52 Tx date 2021-08-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,623.7472
-8,812 vol $1.21 each |
735,526 | |
Filed 2021-08-26 15:31 Tx date 2021-08-16 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,623.7472
-8,812 vol $1.21 each |
162,026 | |
Filed 2021-04-10 22:40 Tx date 2021-04-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,000 vol |
0 | |
Filed 2021-04-10 22:34 Tx date 2021-03-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
5,000 | |
Filed 2021-02-10 16:25 Tx date 2021-02-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-25,456 vol |
0 | |
Filed 2021-02-10 16:24 Tx date 2021-01-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
30,608 | |
Filed 2021-02-10 16:22 Tx date 2021-01-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,606
+5,152 vol $0.70 each |
25,608 | |
Filed 2021-02-10 16:21 Tx date 2021-01-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+5,000 vol $0.70 each |
20,456 | |
Filed 2021-02-10 16:21 Tx date 2021-01-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,606
+5,152 vol $0.70 each |
15,456 | |
Filed 2021-02-10 16:19 Tx date 2021-01-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,606
+5,152 vol $0.70 each |
10,304 | |
Filed 2021-01-18 16:55 Tx date 2021-01-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-5,152 vol |
0 | |
Filed 2021-01-11 22:02 Tx date 2020-12-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,606
+5,152 vol $0.70 each |
5,152 | |
Filed 2021-01-06 14:31 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+15,000 vol |
15,000 | |
Filed 2021-01-06 14:30 Tx date 2020-11-02 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-06 14:24 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+15,000 vol |
15,000 | |
Filed 2021-01-06 14:23 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-06 14:18 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+15,000 vol |
15,000 | |
Filed 2021-01-06 14:17 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-06 14:12 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+22,500 vol |
22,500 | |
Filed 2021-01-06 14:09 Tx date 2018-05-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-06 14:05 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+45,000 vol |
45,000 | |
Filed 2021-01-06 14:04 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-06 13:57 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+150,000 vol |
150,000 | |
Filed 2021-01-06 13:11 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,500 vol |
37,500 | |
Filed 2021-01-06 13:05 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
235,000 | |
Filed 2021-01-06 12:59 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
135,000 | |
Filed 2021-01-06 12:54 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
112,500 | |
Filed 2021-01-06 10:58 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
300,000 | |
Filed 2021-01-05 22:03 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-05 21:55 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
720,000 | |
Filed 2020-12-09 12:55 Tx date 2020-12-04 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,848
+7,596 vol $0.77 each |
84,362 | |
Filed 2020-12-09 12:55 Tx date 2020-12-04 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+2,500 vol $0.76 each |
76,766 | |
Filed 2020-12-02 21:11 Tx date 2020-11-27 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,150
+15,000 vol $0.81 each |
30,000 | |
Filed 2020-12-02 21:07 Tx date 2020-11-02 |
$CTX
Crescita Therapeutics Inc. |
Medina Ramirez, Ivonne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
15,000 | ||
Filed 2020-08-24 15:17 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
744,338 | |
Filed 2020-08-21 23:02 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
64,653 | |
Filed 2020-08-21 22:50 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
67,730 | |
Filed 2020-08-21 22:42 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
64,653 | |
Filed 2020-08-21 22:35 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,000
+20,000 vol $0.60 each |
225,000 | |
Filed 2020-08-21 22:27 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,000
+20,000 vol $0.60 each |
125,000 | |
Filed 2020-08-21 22:18 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+60,000 vol $0.60 each |
270,000 | |
Filed 2020-08-21 22:09 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$108,000
+180,000 vol $0.60 each |
630,000 | |
Filed 2020-08-21 22:02 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
30,000 | |
Filed 2020-08-21 21:47 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+25,000 vol $0.60 each |
100,000 | |
Filed 2020-08-21 21:36 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
170,838 | |
Filed 2020-06-17 16:07 Tx date 2020-06-17 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
734,338 | |
Filed 2020-06-17 15:52 Tx date 2020-06-17 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
160,838 | |
Filed 2020-04-09 15:46 Tx date 2020-03-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-59,141 vol |
0 | |
Filed 2020-04-09 15:45 Tx date 2020-03-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,680
+3,000 vol $0.56 each |
59,141 | |
Filed 2020-04-09 15:44 Tx date 2020-03-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,386
+6,047 vol $0.56 each |
56,141 | |
Filed 2020-04-09 15:40 Tx date 2020-03-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,870
+6,047 vol $0.64 each |
50,094 | |
Filed 2020-04-09 15:38 Tx date 2020-03-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,688
+6,047 vol $0.61 each |
44,047 | |
Filed 2020-04-09 15:37 Tx date 2020-03-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,140
+6,000 vol $0.69 each |
38,000 | |
Filed 2020-04-09 15:36 Tx date 2020-03-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,500
+2,000 vol $0.75 each |
32,000 | |
Filed 2020-04-09 15:36 Tx date 2020-03-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,440
+6,000 vol $0.74 each |
30,000 | |
Filed 2020-04-09 15:34 Tx date 2020-03-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,620
+6,000 vol $0.77 each |
24,000 | |
Filed 2020-04-09 15:32 Tx date 2020-03-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,100
+6,000 vol $0.85 each |
18,000 | |
Filed 2020-04-09 15:30 Tx date 2020-03-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,040
+6,000 vol $0.84 each |
12,000 | |
Filed 2020-04-09 15:27 Tx date 2020-03-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,280
+6,000 vol $0.88 each |
6,000 | |
Filed 2020-03-11 10:05 Tx date 2020-03-06 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-13,047 vol |
0 | |
Filed 2020-03-11 10:04 Tx date 2020-02-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,220
+6,000 vol $0.87 each |
13,047 | |
Filed 2020-03-11 10:03 Tx date 2020-02-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$880.00
+1,000 vol $0.88 each |
7,047 | |
Filed 2020-03-11 10:02 Tx date 2020-02-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,381
+6,047 vol $0.89 each |
6,047 | |
Filed 2020-02-10 18:30 Tx date 2020-02-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-12,000 vol |
0 | |
Filed 2020-02-10 18:27 Tx date 2020-01-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,340
+6,000 vol $0.89 each |
12,000 | |
Filed 2020-02-10 18:27 Tx date 2020-01-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,225
+2,500 vol $0.89 each |
6,000 | |
Filed 2020-02-10 18:26 Tx date 2020-01-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,115
+3,500 vol $0.89 each |
3,500 | |
Filed 2020-01-09 15:46 Tx date 2020-01-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-8,496.83
-9,547 vol $0.89 each |
0 | |
Filed 2020-01-09 15:43 Tx date 2019-12-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,115
+3,500 vol $0.89 each |
9,547 | |
Filed 2020-01-09 15:43 Tx date 2019-12-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,381
+6,047 vol $0.89 each |
6,047 | |
Filed 2019-11-08 15:43 Tx date 2019-11-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-72,359 vol |
0 | |
Filed 2019-11-08 15:42 Tx date 2019-10-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,765
+3,765 vol $1.00 each |
72,359 | |
Filed 2019-11-08 15:41 Tx date 2019-10-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,000
+6,000 vol $1.00 each |
68,594 | |
Filed 2019-11-08 15:41 Tx date 2019-10-24 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,820
+6,000 vol $0.97 each |
62,594 | |
Filed 2019-11-08 15:40 Tx date 2019-10-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,300
+2,500 vol $0.92 each |
56,594 | |
Filed 2019-11-08 15:40 Tx date 2019-10-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,280
+6,000 vol $0.88 each |
54,094 | |
Filed 2019-11-08 15:39 Tx date 2019-10-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,200
+6,047 vol $0.86 each |
48,094 | |
Filed 2019-11-08 15:39 Tx date 2019-10-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,280
+6,000 vol $0.88 each |
42,047 | |
Filed 2019-11-08 15:38 Tx date 2019-10-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+6,000 vol $0.90 each |
36,047 | |
Filed 2019-11-08 15:38 Tx date 2019-10-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,340
+6,000 vol $0.89 each |
30,047 | |
Filed 2019-11-08 15:32 Tx date 2019-10-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,520
+6,000 vol $0.92 each |
24,047 | |
Filed 2019-11-08 15:31 Tx date 2019-10-03 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,280
+6,000 vol $0.88 each |
18,047 | |
Filed 2019-11-08 15:30 Tx date 2019-10-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,260
+6,047 vol $0.87 each |
12,047 | |
Filed 2019-11-08 15:30 Tx date 2019-10-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,340
+6,000 vol $0.89 each |
82,829 | |
Filed 2019-10-10 22:13 Tx date 2019-10-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-69,914.39
-76,829 vol $0.91 each |
0 | |
Filed 2019-10-08 15:10 Tx date 2019-09-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,381
+6,047 vol $0.89 each |
76,829 | |
Filed 2019-10-08 15:10 Tx date 2019-09-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,321
+6,047 vol $0.88 each |
70,782 | |
Filed 2019-10-08 15:09 Tx date 2019-09-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+6,000 vol $0.90 each |
64,735 | |
Filed 2019-10-08 15:09 Tx date 2019-09-25 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,950
+5,500 vol $0.90 each |
58,735 | |
Filed 2019-10-08 15:08 Tx date 2019-09-23 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,340
+6,000 vol $0.89 each |
53,235 | |
Filed 2019-10-08 15:08 Tx date 2019-09-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,442
+6,047 vol $0.90 each |
47,235 | |
Filed 2019-10-08 15:07 Tx date 2019-09-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+6,000 vol $0.90 each |
41,188 | |
Filed 2019-10-08 15:07 Tx date 2019-09-18 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,380
+1,500 vol $0.92 each |
35,188 | |
Filed 2019-10-08 15:06 Tx date 2019-09-17 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,684
+6,047 vol $0.94 each |
33,688 | |
Filed 2019-10-08 15:06 Tx date 2019-09-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,744
+6,047 vol $0.95 each |
27,641 | |
Filed 2019-10-08 15:05 Tx date 2019-09-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,744
+6,047 vol $0.95 each |
21,594 | |
Filed 2019-10-08 15:04 Tx date 2019-09-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,381
+6,047 vol $0.89 each |
15,547 | |
Filed 2019-10-08 15:04 Tx date 2019-09-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+6,000 vol $0.90 each |
9,500 | |
Filed 2019-10-08 15:03 Tx date 2019-09-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,285
+3,500 vol $0.94 each |
3,500 | |
Filed 2019-09-09 22:47 Tx date 2019-09-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-90,047 vol |
0 | |
Filed 2019-09-09 22:43 Tx date 2019-08-29 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,550
+5,000 vol $0.91 each |
90,047 | |
Filed 2019-09-09 22:41 Tx date 2019-08-28 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+6,000 vol $0.90 each |
85,047 | |
Filed 2019-09-09 22:38 Tx date 2019-08-27 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,310
+6,000 vol $0.89 each |
79,047 | |
Filed 2019-09-09 22:35 Tx date 2019-08-26 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,960
+8,000 vol $0.87 each |
73,047 | |
Filed 2019-09-09 22:34 Tx date 2019-08-21 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,800
+6,000 vol $0.80 each |
65,047 | |
Filed 2019-09-09 22:30 Tx date 2019-08-20 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,837
+6,047 vol $0.80 each |
59,047 | |
Filed 2019-09-09 22:29 Tx date 2019-08-19 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,160
+6,000 vol $0.86 each |
53,000 | |
Filed 2019-09-09 22:26 Tx date 2019-08-16 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,220
+6,000 vol $0.87 each |
47,000 | |
Filed 2019-09-09 22:23 Tx date 2019-08-15 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,610
+6,000 vol $0.94 each |
41,000 | |
Filed 2019-09-09 22:18 Tx date 2019-08-14 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,910
+3,000 vol $0.97 each |
35,000 | |
Filed 2019-09-09 22:17 Tx date 2019-08-13 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,850
+6,000 vol $0.97 each |
32,000 | |
Filed 2019-09-09 22:13 Tx date 2019-08-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,970
+3,000 vol $0.99 each |
26,000 | |
Filed 2019-09-09 22:10 Tx date 2019-08-07 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,910
+6,000 vol $0.98 each |
23,000 | |
Filed 2019-09-09 22:04 Tx date 2019-08-02 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,950
+5,000 vol $0.99 each |
17,000 | |
Filed 2019-09-09 22:00 Tx date 2019-08-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,880
+6,000 vol $0.98 each |
12,000 | |
Filed 2019-08-12 15:58 Tx date 2019-08-08 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,000
-20,000 vol $1.10 each |
1,935,489 | |
Filed 2019-08-10 21:28 Tx date 2019-07-31 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-34,641 vol |
6,000 | |
Filed 2019-08-10 21:26 Tx date 2019-07-30 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,000
+6,000 vol $1.00 each |
40,641 | |
Filed 2019-08-10 21:25 Tx date 2019-07-12 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,850
+3,000 vol $0.95 each |
34,641 | |
Filed 2019-08-10 21:24 Tx date 2019-07-11 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,280
+6,000 vol $0.88 each |
31,641 | |
Filed 2019-08-10 21:23 Tx date 2019-07-10 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,400
+6,000 vol $0.90 each |
25,641 | |
Filed 2019-08-10 21:22 Tx date 2019-07-09 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,502
+6,047 vol $0.91 each |
19,641 | |
Filed 2019-08-10 21:21 Tx date 2019-07-08 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,381
+6,047 vol $0.89 each |
13,594 | |
Filed 2019-08-10 21:20 Tx date 2019-07-05 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,215
+1,500 vol $0.81 each |
7,547 | |
Filed 2019-08-10 21:19 Tx date 2019-07-04 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,777
+6,047 vol $0.79 each |
6,047 | |
Filed 2019-08-10 21:17 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-05 10:11 Tx date 2019-08-02 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-750,000
-750,000 vol $1.00 each |
1,955,489 | |
Filed 2019-07-26 10:14 Tx date 2019-07-24 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,551.79
-17,100 vol $1.08 each |
2,705,489 | |
Filed 2019-07-26 10:13 Tx date 2019-07-24 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,090
-20,000 vol $1.05 each |
2,722,589 | |
Filed 2019-07-23 17:07 Tx date 2019-07-23 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,250
-5,000 vol $1.05 each |
2,742,589 | |
Filed 2019-07-19 12:44 Tx date 2019-07-17 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,390.01
-2,100 vol $1.14 each |
2,747,589 | |
Filed 2019-07-19 12:43 Tx date 2019-07-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,692.50
-25,000 vol $1.19 each |
2,749,689 | |
Filed 2019-07-19 12:42 Tx date 2019-07-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,800
-10,000 vol $1.18 each |
2,774,689 | |
Filed 2019-07-19 12:41 Tx date 2019-07-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,950
-20,000 vol $1.15 each |
2,784,689 | |
Filed 2019-07-19 12:40 Tx date 2019-07-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,300
-10,000 vol $1.13 each |
2,804,689 | |
Filed 2019-07-19 12:38 Tx date 2019-07-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,925
-10,000 vol $1.09 each |
2,814,689 | |
Filed 2019-07-19 12:36 Tx date 2019-07-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,300
-10,000 vol $1.13 each |
||
Filed 2019-07-19 12:22 Tx date 2019-07-15 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,800
-10,000 vol $1.08 each |
2,824,689 | |
Filed 2019-05-25 14:53 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,200
+40,000 vol $0.78 each |
40,000 | |
Filed 2019-05-25 14:52 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
57,730 | |
Filed 2019-05-25 14:51 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,600
+20,000 vol $0.78 each |
20,000 | |
Filed 2019-05-25 14:49 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
177,446 | |
Filed 2019-05-25 14:47 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
54,653 | |
Filed 2019-05-25 14:46 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
750,946 | |
Filed 2019-05-25 14:44 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
54,653 | |
Filed 2019-05-24 12:28 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,200
+40,000 vol $0.78 each |
||
Filed 2019-05-24 12:23 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,600
+20,000 vol $0.78 each |
||
Filed 2019-05-24 12:13 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
Filed 2019-05-24 12:09 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
Filed 2019-05-24 12:07 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
Filed 2019-05-24 12:04 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
Filed 2019-05-24 12:00 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
Filed 2019-05-24 12:28 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,200
+40,000 vol $0.78 each |
40,000 | |
Filed 2019-05-24 12:27 Tx date 2019-05-01 |
$CTX
Crescita Therapeutics Inc. |
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-24 12:23 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,600
+20,000 vol $0.78 each |
20,000 | |
Filed 2019-05-24 12:21 Tx date 2019-05-14 |
$CTX
Crescita Therapeutics Inc. |
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-24 12:13 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
57,730 | |
Filed 2019-05-24 12:09 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
177,446 | |
Filed 2019-05-24 12:07 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
54,653 | |
Filed 2019-05-24 12:04 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
750,946 | |
Filed 2019-05-24 12:00 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
54,653 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
205,000 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
450,000 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
167,446 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
44,653 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
75,000 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
47,730 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
210,000 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
47,730 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
||
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
44,653 | |
Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
105,000 | |
Filed 2019-01-03 Tx date 2019-01-03 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,195 vol |
0 | |
Filed 2019-01-03 Tx date 2019-01-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,195 vol |
0 | |
Filed 2018-06-22 Tx date 2018-06-15 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,811.625
-11,250 vol $0.4277 each |
180,000 | |
Filed 2018-06-22 Tx date 2018-06-15 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,811
+11,250 vol $0.4277 each |
39,384 | |
Filed 2018-05-30 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-40,999.74
-77,358 vol $0.53 each |
0 | |
Filed 2018-05-30 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+77,358 vol |
77,358 | |
Filed 2018-05-30 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-05-30 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$20,499
+38,679 vol $0.53 each |
124,879 | |
Filed 2018-05-15 Tx date 2018-05-14 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
Filed 2018-05-15 Tx date 2018-05-01 |
$CTX
Crescita Therapeutics Inc. |
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-05-09 Tx date 2018-05-09 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,688 vol |
34,653 | |
Filed 2018-05-09 Tx date 2018-05-06 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,688 vol |
34,653 | |
Filed 2018-04-12 Tx date 2018-04-06 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+20,000 vol $0.48 each |
117,132 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+180,000 vol |
250,000 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,730 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,730 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
157,446 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
191,250 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
80,000 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,341 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
130,000 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,341 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
740,946 | |
Filed 2018-03-29 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
Filed 2018-03-29 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
Filed 2018-03-29 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
147,446 | |
Filed 2018-03-29 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
Filed 2018-03-29 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
730,946 | |
Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$407.57
+769 vol $0.53 each |
1,538 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$4,000
+7,548 vol $0.53 each |
7,548 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$3,736
+7,050 vol $0.53 each |
14,100 | |
Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$224,106
+422,842 vol $0.53 each |
645,999 | |
Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$20,561
+38,795 vol $0.53 each |
38,795 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$5,499
+10,377 vol $0.53 each |
119,577 | |
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+514,028 vol |
514,028 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-500,334.84
-944,028 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,999
+37,735 vol $0.53 each |
95,427 | |
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+75,637 vol |
75,637 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-40,087.61
-75,637 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$51,479
+97,132 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$51,479
+97,132 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$51,479
+97,132 vol $0.53 each |
97,132 | |
Filed 2018-03-16 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+194,264 vol |
194,264 | |
Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+75,470 vol |
75,470 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-39,999.10
-75,470 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$52,765
+99,558 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$52,765
+99,558 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$52,765
+99,558 vol $0.53 each |
100,558 | |
Filed 2018-03-16 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+201,116 vol |
||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+201,116 vol |
||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+199,116 vol |
||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+199,116 vol |
||
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+199,116 vol |
199,116 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-106,591.48
-201,116 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-106,591.48
-201,116 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-105,531.48
-199,116 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-105,531.48
-199,116 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-105,531.48
-199,116 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,900
+30,000 vol $0.53 each |
74,266 | |
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+194,264 vol |
388,528 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-102,959.92
-194,264 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-102,959.92
-194,264 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-40,000.16
-75,472 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+75,472 vol |
75,472 | |
Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$15,999
+30,188 vol $0.53 each |
30,188 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-102,959.92
-194,264 vol $0.53 each |
194,264 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-287,516.52
-542,484 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+542,484 vol |
542,484 | |
Filed 2018-03-16 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$143,758
+271,242 vol $0.53 each |
649,351 | |
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-17,428.52
-32,884 vol $0.53 each |
0 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
-32,884 vol |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
-32,884 vol |
||
Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+32,884 vol |
32,884 | |
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+32,884 vol |
||
Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+32,884 vol |
||
Filed 2018-03-16 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,714
+16,442 vol $0.53 each |
36,681 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,714
+16,442 vol $0.53 each |
||
Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,714
+16,442 vol $0.53 each |
||
Filed 2018-03-13 Tx date 2018-03-12 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$399,999
+754,716 vol $0.53 each |
2,834,689 | |
Filed 2018-03-13 Tx date 2018-03-12 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-799,998.96
-1,509,432 vol $0.53 each |
0 | |
Filed 2018-03-12 Tx date 2018-03-07 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
10 - Acquisition or disposition in the public market
|
$-5,705.41
-570,541 vol $0.01 each |
1,509,432 | |
Filed 2018-03-09 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+2,079,973 vol |
2,079,973 | |
Filed 2018-03-09 Tx date 2018-03-08 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
10 - Acquisition or disposition in the public market
|
$4,300
+430,000 vol $0.01 each |
430,000 | |
Filed 2018-03-09 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-09 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-21 Tx date 2018-02-20 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,691 vol |
145,734 | |
Filed 2018-02-12 Tx date 2018-01-22 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$710.00
+1,000 vol $0.71 each |
1,000 | |
Filed 2018-02-12 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-03 Tx date 2018-01-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-39,377 vol |
17,195 | |
Filed 2018-01-03 Tx date 2018-01-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-19,248 vol |
8,407 | |
Filed 2018-01-03 Tx date 2018-01-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-39,377 vol |
17,195 | |
Filed 2017-12-14 Tx date 2017-12-13 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2017-12-14 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-12-08 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
147,446 | |
Filed 2017-12-08 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
730,946 | |
Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,087
+103,600 vol $0.58 each |
116,227 | |
Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,250
+15,000 vol $0.55 each |
378,109 | |
Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,813
+275,541 vol $0.58 each |
363,109 | |
Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,996
+86,200 vol $0.58 each |
109,200 | |
Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,996
+86,200 vol $0.58 each |
86,200 | |
Filed 2017-12-07 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-10-11 Tx date 2017-10-06 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+566,471 vol |
2,079,973 | |
Filed 2017-09-18 Tx date 2017-09-13 |
$CTX
Crescita Therapeutics Inc. |
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,930
+8,500 vol $0.58 each |
17,246 | |
Filed 2017-09-11 Tx date 2017-09-08 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,050
+5,000 vol $0.61 each |
44,266 | |
Filed 2017-09-06 Tx date 2017-09-01 |
$CTX
Crescita Therapeutics Inc. |
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,280
+2,000 vol $0.64 each |
8,746 | |
Filed 2017-08-24 Tx date 2017-08-24 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+67,568 vol $0.74 each |
87,568 | |
Filed 2017-08-17 Tx date 2017-08-14 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+216,000 vol |
216,000 | |
Filed 2017-08-17 Tx date 2017-08-14 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+180,000 vol |
396,000 | |
Filed 2017-08-17 Tx date 2017-08-14 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-293,163 vol |
0 | |
Filed 2017-07-11 Tx date 2017-07-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$620.00
+1,000 vol $0.62 each |
18,000 | |
Filed 2017-07-11 Tx date 2017-07-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,100
+5,000 vol $0.62 each |
23,000 | |
Filed 2017-07-11 Tx date 2017-07-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+4,000 vol $0.66 each |
17,000 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,550
+7,000 vol $0.65 each |
12,000 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+1,500 vol $0.66 each |
20,000 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+2,000 vol $0.65 each |
18,500 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+500 vol $0.72 each |
16,500 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,450
+3,500 vol $0.70 each |
16,000 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$670.00
+1,000 vol $0.67 each |
12,500 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,625
+11,500 vol $0.75 each |
11,500 | |
Filed 2017-07-04 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$750.00
+1,000 vol $0.75 each |
13,000 | |
Filed 2017-07-04 Tx date 2017-06-29 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+5,000 vol $0.65 each |
5,000 | |
Filed 2017-07-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-28 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
70,000 | |
Filed 2017-06-28 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
27,730 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
27,730 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
201,292 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
169,421 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
151,250 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
Filed 2017-06-28 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
27,341 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
27,341 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
784,792 | |
Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
Filed 2017-05-31 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,150 | ||
Filed 2017-05-31 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,746 | ||
Filed 2017-05-05 Tx date 2017-05-05 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,050 vol |
8,841 | |
Filed 2017-05-05 Tx date 2017-05-05 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,050 vol |
8,841 | |
Filed 2017-02-16 Tx date 2017-02-09 |
$CTX
Crescita Therapeutics Inc. |
Kanji, Muneerah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-02-16 Tx date 2017-02-09 |
$CTX
Crescita Therapeutics Inc. |
Kanji, Muneerah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-76,269.30
-64,635 vol $1.18 each |
73,765 | |
Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-76,269.30
-64,635 vol $1.18 each |
73,765 | |
Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,193 vol |
56,572 | |
Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,193 vol |
56,572 | |
Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-8,404 vol |
59,250 | |
Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-37,282.10
-31,595 vol $1.18 each |
27,655 | |
Filed 2016-10-03 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,230 vol |
9,230 | |
Filed 2016-10-03 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-10-03 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,230 vol |
9,230 | |
Filed 2016-10-03 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-30 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,778 | ||
Filed 2016-09-08 Tx date 2016-09-06 |
$CTX
Crescita Therapeutics Inc. |
Laflamme, Mario
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+38,000 vol |
38,000 | |
Filed 2016-09-08 Tx date 2016-09-06 |
$CTX
Crescita Therapeutics Inc. |
Orleski, Gregory M.C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
90,000 | |
Filed 2016-09-08 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Orleski, Gregory M.C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-08 Tx date 2016-09-06 |
$CTX
Crescita Therapeutics Inc. |
Laflamme, Mario
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-06 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,239 | ||
Filed 2016-09-06 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Orleski, Gregory M.C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
827,690 | ||
Filed 2016-09-02 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
293,163 | ||
Filed 2016-09-02 Tx date 2016-09-01 |
$CTX
Crescita Therapeutics Inc. |
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,513,502 | ||
Filed 2016-06-27 Tx date 2016-06-27 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
Filed 2016-06-27 Tx date 2016-06-27 |
$CTX
Crescita Therapeutics Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
Filed 2016-06-27 Tx date 2016-06-27 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-418 vol |
9,891 | |
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
28,134 | ||
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+103,000 vol |
153,425 | |
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
146,637 | |
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
129,421 | |
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
29,421 | ||
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
15,564 | ||
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
111,250 | |
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
11,250 | ||
Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+302,000 vol |
484,792 | |
Filed 2016-03-14 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-03-14 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
138,400 | ||
Filed 2016-03-14 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-03-14 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
138,400 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
61,637 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
9,228 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Holder: Stanley Research Foundation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,904 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
111,127 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
67,654 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,425 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
871 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,400 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,465 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
138,040 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
182,792 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
155,786 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
35,200 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,309 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
223,157 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,627 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
182,792 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
138,040 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
57,692 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Copeland, David A.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,309 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
39,266 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
769 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,050 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,309 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
15,017 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
121,860 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
72,597 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
78,046 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
19,652 | ||
Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,341 |